Wealth Alliance Charles River Laboratories International, Inc. Transaction History

Wealth Alliance

$818 Million
Q3 2024

A detailed history of Wealth Alliance transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wealth Alliance holds 1,905 shares of CRL stock, worth $354,882. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,905

Previous 1,868 1.98%

Holding current value

$354,882

Previous $385,000 2.6%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$187.96 - $245.29 $6,954 - $9,075	37 Added 1.98%	1,905 $375,000
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $2,063 - $2,687	10 Added 0.54%	1,868 $385,000
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $1,221 - $1,640	6 Added 0.32%	1,858 $503,000
Q4 2023 Jan 30, 2024	SELL	$164.52 - $238.84 $3,619 - $5,254	-22 Reduced 1.17%	1,852 $437,000
Q3 2023 Nov 09, 2023	SELL	$194.44 - $217.61 $9,527 - $10,662	-49 Reduced 2.55%	1,874 $367,000
Q2 2023 Aug 02, 2023	BUY	$183.71 - $210.25 $43,171 - $49,408	235 Added 13.92%	1,923 $404,000
Q1 2023 May 10, 2023	SELL	$191.89 - $259.92 $15,734 - $21,313	-82 Reduced 4.63%	1,688 $340,000
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $69,579 - $88,274	353 Added 24.91%	1,770 $385,000
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $45,974 - $63,136	-252 Reduced 15.1%	1,417 $279,000
Q2 2022 Oct 11, 2022	BUY	$204.13 - $302.4 $66,342 - $98,279	325 Added 24.18%	1,669 $358,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $51,032 - $75,600	-250 Reduced 15.68%	1,344 $288,000
Q1 2022 May 10, 2022	BUY	$255.51 - $362.11 $7,409 - $10,501	29 Added 1.85%	1,594 $453,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $20,731 - $26,472	-59 Reduced 3.63%	1,565 $590,000
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $8,943 - $10,999	-24 Reduced 1.46%	1,624 $670,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $32,947 - $41,624	112 Added 7.29%	1,648 $610,000
Q1 2021 May 18, 2021	BUY	$249.67 - $299.48 $21,221 - $25,455	85 Added 5.86%	1,536 $445,000
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $53,724 - $61,134	-242 Reduced 14.29%	1,451 $362,000
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $5,266 - $6,793	30 Added 1.8%	1,693 $383,000
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $197,630 - $315,504	1,663 New	1,663 $290,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account